Skip to main content
Equibles
URGN logo

URGN · UroGen Pharma Ltd. · Share Buybacks

Track URGN — free

Use URGN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research URGN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$40.55 -0.08 (-0.20%) At close · Oct 1
Russell 2000 member Rebalance outlook locked
Market Cap
$2.02B
Shares
48.88M
Volume · Oct 1 624.62K Avg daily vol (3M) 829.88K

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Equity Offering (ATM) Programs

Program Established Capacity Remaining Runs Through
2019-12-20 $75,000,000 $42,400,000 as of 2026-03-31 —
Key facts CIK 1668243 CUSIP M96088105 13F (30d) 6 filings 6 filers Visit website Investor relations